litlas
Log inCreate account

Stephen D. Silberstein

Active 1970–2025

179
Papers
34,540
Citations
106
h-index
177
i10-index

Citations

Citations per year for Stephen D. Silberstein1971: 3 citations1972: 6 citations1973: 1 citations1974: 1 citations1976: 1 citations1980: 1 citations1981: 3 citations1982: 1 citations1987: 1 citations1989: 1 citations1991: 1 citations1992: 4 citations1993: 6 citations1994: 8 citations1995: 10 citations1996: 15 citations1997: 35 citations1998: 19 citations1999: 34 citations2000: 55 citations2001: 74 citations2002: 124 citations2003: 116 citations2004: 137 citations2005: 134 citations2006: 161 citations2007: 161 citations2008: 138 citations2009: 206 citations2010: 154 citations2011: 129 citations2012: 138 citations2013: 187 citations2014: 163 citations2015: 223 citations2016: 219 citations2017: 254 citations2018: 324 citations2019: 1,159 citations2020: 1,163 citations2021: 1,224 citations2022: 902 citations2023: 751 citations2024: 1,060 citations2025: 391 citations2026: 10 citations1975: no citations, so this year is not shown1977–1979: no citations, so these years are not shown1983–1986: no citations, so these years are not shown1988: no citations, so this year is not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,278 citing papers, 29.5% of this breakdownUnited Kingdom: 668 citing papers, 8.7% of this breakdownItaly: 535 citing papers, 6.9% of this breakdownGermany: 501 citing papers, 6.5% of this breakdownChina: 332 citing papers, 4.3% of this breakdownDenmark: 327 citing papers, 4.2% of this breakdownSpain: 268 citing papers, 3.5% of this breakdownNetherlands: 238 citing papers, 3.1% of this breakdownCanada: 196 citing papers, 2.5% of this breakdownFrance: 144 citing papers, 1.9% of this breakdownAustralia: 136 citing papers, 1.8% of this breakdownSwitzerland: 134 citing papers, 1.7% of this breakdown
0%29.5%Other 25.4%

Institutions

Fields

  • Medicine84.3%
  • Neuroscience10.6%
  • Biochemistry, Genetics and Molecular Biology1.8%
  • Psychology0.8%
  • Health Professions0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other1.3%

Topics

  • Migraine and Headache Studies23.5%
  • Trigeminal Neuralgia and Treatments6%
  • Neurological Complications and Syndromes5.2%
  • Traumatic Brain Injury Research3.5%
  • Sympathectomy and Hyperhidrosis Treatments3.5%
  • Vagus Nerve Stimulation Research3%
  • Other55.3%

Coauthors

All papers

Open in search
  1. Fremanezumab for the Preventive Treatment of Chronic Migraine

    Authors: Stephen D. Silberstein, David W. Dodick, Marcelo E. Bigal, Paul Yeung, Peter J. Goadsby, Tricia Blankenbiller, Melissa Grozinski‐Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi - New England Journal of Medicine 2017 cited by 803

  2. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

    Authors: Stewart J. Tepper, Messoud Ashina, Uwe Reuter, Jan Lewis Brandes, David Doležil, Stephen D. Silberstein, Paul Winner, Dean Leonardi, Daniel D. Mikol, Robert Lenz - The Lancet Neurology 2017 cited by 735

  3. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine

    Authors: David W. Dodick, Stephen D. Silberstein, Marcelo E. Bigal, Paul Yeung, Peter J. Goadsby, Tricia Blankenbiller, Melissa Grozinski‐Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi - JAMA 2018 cited by 573

  4. Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part I

    Authors: Hsiangkuo Yuan, Stephen D. Silberstein - Headache The Journal of Head and Face Pain 2015 cited by 396

  5. Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

    Authors: Cristina Tassorelli, Hans‐Christoph Diener, David W. Dodick, Stephen D. Silberstein, Richard B. Lipton, Messoud Ashina, Werner J. Becker, Michel D. Ferrari, Peter J. Goadsby, Patricia Pozo‐Rosich, Shuu‐Jiun Wang - Cephalalgia 2018 cited by 385

  6. Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part III

    Authors: Hsiangkuo Yuan, Stephen D. Silberstein - Headache The Journal of Head and Face Pain 2015 cited by 380

  7. OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

    Authors: David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse, Sheena K. Aurora, Stephen D. Silberstein, Richard B. Lipton, Hans‐Christoph Diener, Mitchell F. Brin - Headache The Journal of Head and Face Pain 2010 cited by 986

  8. The Acute Treatment of Migraine in Adults: The A merican H eadache S ociety Evidence Assessment of Migraine Pharmacotherapies

    Authors: Michael J. Marmura, Stephen D. Silberstein, Todd J. Schwedt - Headache The Journal of Head and Face Pain 2015 cited by 571

  9. Cutaneous allodynia in the migraine population

    Authors: Richard B. Lipton, Marcelo E. Bigal, Sait Ashina, Rami Burstein, Stephen D. Silberstein, Michael L. Reed, Daniel Serrano, Walter F. Stewart, American Migraine Prevalence Prevention Advisory Group - Annals of Neurology 2007 cited by 587

  10. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults

    Authors: Stephen D. Silberstein, Starr Holland, F. G. Freitag, David W. Dodick, Charles E. Argoff, Eric Ashman - Neurology 2012 cited by 889

  11. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults

    Authors: Hans‐Christoph Diener, Cristina Tassorelli, David W. Dodick, Stephen D. Silberstein, Richard B. Lipton, Messoud Ashina, Werner J. Becker, Michel D. Ferrari, Peter J. Goadsby, Patricia Pozo‐Rosich, Shuu‐Jiun Wang, Timothy T. Houle, Thomas C. van den Hoek, Daniele Martinelli, Gisela M. Terwindt - Cephalalgia 2020 cited by 216

  12. Surgically implanted and non‐invasive vagus nerve stimulation: a review of efficacy, safety and tolerability

    Authors: E. Ben‐Menachem, David Révész, Bruce J. Simon, Stephen D. Silberstein - European Journal of Neurology 2015 cited by 334

  13. Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part II

    Authors: Hsiangkuo Yuan, Stephen D. Silberstein - Headache The Journal of Head and Face Pain 2015 cited by 295

  14. Preventive Migraine Treatment

    Authors: Stephen D. Silberstein - CONTINUUM Lifelong Learning in Neurology 2009 cited by 303

  15. Premonitory symptoms in migraine

    Authors: Nicola Giffin, Lucia Ruggiero, Richard B. Lipton, Stephen D. Silberstein, Jesper Filtenborg Tvedskov, Jes Olesen, Julie S. Altman, Peter J. Goadsby, Alastair Macrae - Neurology 2003 cited by 649

  16. Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review

    Authors: Rami Burstein, Andrew Blumenfeld, Stephen D. Silberstein, Aubrey Manack Adams, Mitchell F. Brin - Headache The Journal of Head and Face Pain 2020 cited by 203

  17. Chronic versus episodic migraine: The 15‐day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency

    Authors: Ryotaro Ishii, Todd J. Schwedt, Gina Dumkrieger, Nim Lalvani, Audrey Craven, Peter J. Goadsby, Richard B. Lipton, Jes Olesen, Stephen D. Silberstein, Mark J. Burish, David W. Dodick - Headache The Journal of Head and Face Pain 2021 cited by 107

  18. Psychiatric comorbidities of episodic and chronic migraine

    Authors: Dawn C. Buse, Stephen D. Silberstein, Aubrey Manack, Spyros Papapetropoulos, Richard B. Lipton - Journal of Neurology 2012 cited by 387

  19. Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition

    Authors: Hans‐Christoph Diener, Cristina Tassorelli, David W. Dodick, Stephen D. Silberstein, Richard B. Lipton, Messoud Ashina, Werner J. Becker, Michel D. Ferrari, Peter J. Goadsby, Patricia Pozo‐Rosich, Shuu‐Jiun Wang, Jay Mandrekar - Cephalalgia 2019 cited by 236

  20. Long-term safety, tolerability, and efficacy of fremanezumab in migraine

    Authors: Peter J. Goadsby, Stephen D. Silberstein, Paul Yeung, Joshua M. Cohen, Xiaoping Ning, Ronghua Yang, David W. Dodick - Neurology 2020 cited by 177

  21. Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention

    Authors: Richard B. Lipton, Stephen D. Silberstein - Headache The Journal of Head and Face Pain 2015 cited by 322

  22. The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

    Authors: Stephen D. Silberstein, Joshua M. Cohen, Michael J. Seminerio, Ronghua Yang, Sait Ashina, Zaza Katsarava - The Journal of Headache and Pain 2020 cited by 129

  23. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

    Authors: Richard B. Lipton, David W. Dodick, Stephen D. Silberstein, Joel R. Saper, Sheena K. Aurora, Starr H. Pearlman, Robert E. Fischell, Patricia L. Ruppel, Peter J. Goadsby - The Lancet Neurology 2010 cited by 464

  24. Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial

    Authors: Hong Sun, David W. Dodick, Stephen D. Silberstein, Peter J. Goadsby, Uwe Reuter, Messoud Ashina, Joel R. Saper, Roger Cady, Yun Chon, Julie Dietrich, Robert Lenz - The Lancet Neurology 2016 cited by 360